TSTA3 (Tissue Specific Transplantation Antigen P35B, Protein FX, GDP-L-fucose Synthase, Red Cell NADP(H)-binding Protein, Short-chain Dehydrogenase/Reductase Family 4E Member 1, GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reducta
TSTA3 (Tissue Specific Transplantation Antigen P35B, Protein FX, GDP-L-fucose Synthase, Red Cell NADP(H)-binding Protein, Short-chain Dehydrogenase/Reductase Family 4E Member 1, GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reducta
TSTA3 (Tissue Specific Transplantation Antigen P35B, Protein FX, GDP-L-fucose Synthase, Red Cell NADP(H)-binding Protein, Short-chain Dehydrogenase/Reductase Family 4E Member 1, GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reducta
Biozol Catalog Number:
USB-T9135-01-HRP
Supplier Catalog Number:
T9135-01-HRP
Alternative Catalog Number:
USB-T9135-01-HRP-100
Manufacturer:
US Biological
Host:
Mouse
Category:
Antikörper
Application:
ELISA, WB
Immunogen:
TSTA3 (NP_003304, 222-322aa) partial recombinant protein with GST tag. MW of the GST tag alone is 26kD.
Tissue specific transplantation antigen P35B is a NADP(H)-binding protein. It catalyze the two-step epimerase and the reductase reactions in GDP-D-mannose metabolism, converting GDP-4-keto-6-D-deoxymannose to GDP-L-fucose. GDP-L-fucose is the substrate of several fucosyltransferases involved in the expression of many glycoconjugates, including blood group ABH antigens and developmental adhesion antigens. Mutations in this gene may cause leukocyte adhesion deficiency, type II. Applications: Suitable for use in ELISA and Western Blot. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4C. For long-term storage, aliquot and store at 4C. Do not freeze. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer. Note: Sodium azide is a potent inhibitor of peroxidase and should not be added to HRP conjugates. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Note: Applications are based on unconjugated antibody.
